Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

PPI-368 selected for development

April 5, 1996

Schering-Plough claims felbamate metabolite

April 5, 1996

Roche Bioscience claims antiemetic drugs

April 5, 1996

SYM-2206 for seizure prevention

April 5, 1996

Anticonvulsants claimed by Bristol-Myers Squibb

April 5, 1996

Stanford investigators identify epilepsy gene

April 5, 1996

Synthelabo reports antidepressants

April 5, 1996

5-HT1A/5-HT2C receptor ligands from Roche

April 5, 1996

New anthranilide in phase I at Glaxo Wellcome

April 5, 1996

L-745870: D4 antagonist for schizophrenia

April 5, 1996

Popular Stories

FDA says changes in Dexcom G6, G7 sensors constitute misbranding
BioWorld MedTech
The U.S. FDA’s March 4, 2025, warning letter to Dexcom Inc. is a well-detailed but heavily redacted document explaining the agency’s misgivings about procedures...
Today's news in brief
BioWorld
BioWorld briefs for March 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 28, 2025
CMV history cited in DMD liver death on Sarepta’s Elevidys
BioWorld
Wall Street was weighing the gravity of the death from acute liver failure of a patient who was treated for Duchenne muscular dystrophy (DMD) with Sarepta...
UK government abolishes NHS England
BioWorld MedTech
In a move that surprised many across the health care sector, the U.K. government decided to scrap NHS England, the body which runs the national health service...